title: [Janus kinase inhibitors as a new therapeutic principle].
authors.affiliation: sh@medpharm-text.de
authors.forename: Susanne
authors.initials: S
authors.lastname: Heinzl
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000473:pathology; D003093:Colitis, Ulcerative / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors* / Q000187:drug effects; D009570:Nitriles; D010880:Piperidines; D055728:Primary Myelofibrosis / Q000188:drug therapy / Q000473:pathology; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D004791:Enzyme Inhibitors; D009570:Nitriles; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; D011758:Pyrroles; C540383:ruxolitinib; C479163:tofacitinib; D053612:Janus Kinases